Releases - Medicover

View:
 

Found press releases

 

Highlights January – September 2006

• Revenue for the nine months amounted to € 54.4 (€ 42.4 million), representing 28 percent growth versus last year. Excluding the acquisition effect, the revenue growth was 23 percent.

• Revenue for the third quarter amounted to € 18.4 million (€ 15.0 million), representing 22 percent revenue growth versus the corresponding period last year. Excluding the acquisition effect, the revenue growth was 20...

The extraordinary general meeting decided today on a de-listing of the company’s...

• The extraordinary general meeting decided today on a de-listing of the company’s SDRs listed on the Stockholm Stock Exchange

• Shareholders, representing 92% of the total share capital and votes in the company, and 100% of shares represented at today’s extraordinary general meeting, voted for the board’s proposal

• Last trading day will be 7th December 2006


The extraordinary general meeting (EGM)...

The board of Medicover has decided to call an extraordinary general meeting on 9...

•The board of Medicover has decided to call an extraordinary general meeting on 9th November 2006 to decide on a de-listing as a consequence of that the company does not comply with the listing requirements for the Stockholm Stock Exchange’s regarding diversification of the shareholder base

•Shareholders, representing 93%, supports the board’s proposal

•Celox, including related parties, controls 82% of the shares...

Celox has increased its ownership to 72% in Medicover at final acceptance period

Celox S.A. (”Celox”) has reached 71.6% of the shares and votes in Medicover Holding S.A. (”Medicover”). In total, Celox has increased its ownership with 5,201,027 shares, representing 36.5% of the shares and votes in Medicover. This has been achieved by tendered shares into the offer of 3,927,274 shares, representing 27.6% of the shares and votes in Medicover and that Celox has acquired 1,273,753 shares,...

Celox extends the offer on Medicover

• Celox reaches 70.7% of shares and votes in Medicover
• The acceptance period is extended until 1 September 2006


Celox S.A. (”Celox”) has reached 70.7% of the shares and votes in Medicover Holding S.A. (”Medicover”). In total, Celox has increased its ownership with 5,075,083 shares, representing 35.6% of the shares and votes in Medicover. This has been achieved by tendered shares into the offer of 3,819,930...

CELOX’S OFFER DECLARED UNCONDITIONAL

Celox S.A. announces that all conditions to the offer to the shareholders in Medicover Holding S.A. have been satisfied and that the offer is unconditional. CELOX S.A. Contact details: Fredrik Stenmo, Celox S.A. Phone: +32 2 357 55 77

Highlights January – June 2006

• Revenue for the 6-month period ending 30 June 2006 amounted to € 36.0 million (€ 27.4 million), representing 31 percent revenue growth versus the corresponding period last year. Excluding acquisition effects, the revenue growth was 24 percent.

• Revenue for the quarter ending 30 June 2006 amounted to € 18.1 million (€ 14.1 million), representing 28 percent revenue growth versus the corresponding period last year....

The offer document relating to Celox tender offer for all shares in Medicover, i...

The offer document is available at Medicover’s website (www.medicover.com). It will be sent out to the direct registered shareholders (in VPC and in the company’s share register) during the next couple of days. Shareholders that hold SDRs through a nominee will receive information from its respective nominee.

Timeplan

Acceptance period 24 July – 18 August 2006

Estimated settlement 1 September 2006


Further...

NEW PUBLICATION DATE FOR THE 6 MONTH REPORT

As a consequence of the public offer announced by Celox on 30th June 2006 for all shares in Medicover, the publication date of the six month report will be on Monday 31 July 2006.


Medicover Holding S.A.
Board of Directors



Contacts

Fredrik Rågmark
Chief Executive Officer
Phone: +32 475 751964
E-mail:  


Joe Ryan
Chief Financial Officer
Phone: +32 477 560382
E-mail:...

Statement of the Board of Directors of Medicover Holding S.A. in relation to Cel...

June 30, 2006
Background

Celox S.A. (“Celox”) has on June 30, 2006 announced a cash offer to the registered shareholders and holders of Swedish depositary receipts (“SDRs”) regarding shares in Medicover Holding S.A. (“Medicover”) to acquire all of their shares and SDRs in Medicover (the “Offer”).
The shareholders and holders of SDRs are being offered to tender their shares and SDRs to Celox for the...

Medicover


  CONTACT